#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	10480	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2115	485.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1381	1381	C	590	C	562	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3410	568.8	0	.	n	.	0	T695C	SNP	695	695	T	950	950	C	558	C,T	538,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3410	568.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1592	1592	A	674	A,G	649,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3410	568.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2226	2226	C	618	C	593	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3410	568.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2300	2300	A	588	A	573	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3410	568.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2852	2852	C	570	C,G	551,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	13634	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	1573	855.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1338	folP	855	855	99.88	folP.l15.c4.ctg.1	1648	80.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1097	1099	AGC	130;131;130	A;G;C	127;128;125	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	4320	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3598	118.8	0	.	p	.	0	G95A	NONSYN	283	285	GGC	659	661	GCC	144;145;145	G;C;C	140;141;138	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	4320	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3598	118.8	1	SNP	p	S91F	1	.	.	271	273	TTC	647	649	TTC	144;142;141	T;T;C	135;133;131	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1164	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1089	103.6	1	SNP	p	G45D	0	.	.	133	135	GGC	345	347	GGC	141;140;140	G;G;C	140;138;135	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	656	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	963	66.9	0	.	n	.	0	A197.	DEL	197	197	A	529	529	A	157	A	152	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	539	3686	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2952	123.3	1	SNP	p	S87I	1	S87I	NONSYN	259	261	AGT	603	605	ATT	154;152;151	A;T;T	149;149;148	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	539	3686	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2952	123.3	0	.	p	.	0	L479F	NONSYN	1435	1437	CTT	1779	1781	TTT	156;153;150	T;T;T	154;150;149	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	539	3686	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2952	123.3	1	SNP	p	D86N	0	.	.	256	258	GAC	600	602	GAC	155;155;154	G;A;C	151;150;150	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	539	3686	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2952	123.3	1	SNP	p	S88P	0	.	.	262	264	TCC	606	608	TCC	149;151;153	T;C;C	145;145;147	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	2792	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2699	102.1	0	.	p	.	0	P456S	NONSYN	1366	1368	CCC	1719	1721	TCC	137;139;141	T;C;C	128;134;134	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	2792	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2699	102.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1581	1583	GGC	115;115;115	G;G;C,G	109;109;105,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1236	1238	GCA	148;149;150	G;C;A	145;142;147	penA.43.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1239	1241	ATC	150;150;153	A;T;C	149;144;152	penA.43.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1251	1253	GTG	154;154;154	G;T;G	149;147;150	penA.43.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1251	1253	GTG	154;154;154	G;T;G	149;147;150	penA.43.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1755	1757	ACC	137;137;138	A;C;C	127;131;131	penA.43.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1809	1811	GTG	135;130;130	G;T,G;G	129;97,8;125	penA.43.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1809	1811	GTG	135;130;130	G;T,G;G	129;97,8;125	penA.43.002:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1932	1934	GGC	113;111;108	G;G,A;C	109;107,1;107	penA.43.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1941	1943	GGC	101;99;97	G;G;C	96;96;94	penA.43.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	27	2866	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2361	119.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1959	1961	CCG	79;77;82	C;C,G;G,C	73;70,1;70,1	penA.43.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4440	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3116	140.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1657	1659	CCG	160;163;164	C;C;G	152;156;157	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1730	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1869	91.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	434	436	GGC	113;111;111	G;G;C	107;105;103	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1730	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1869	91.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	616	616	C	121	C	114	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	297	90.7	porB1a.l15.c30.ctg.2	513	16.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	239	241	AAT	15;15;15	A;A;T	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	297	90.7	porB1a.l15.c30.ctg.2	513	16.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	242	244	AAT	15;15;15	A;A;T	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	297	90.7	porB1a.l15.c30.ctg.2	513	16.9	0	.	p	.	0	A222V	NONSYN	664	666	GCT	254	256	GTT	14;14;14	G;T;T	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	297	90.7	porB1a.l15.c30.ctg.2	513	16.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	266	268	GCA	14;13;13	G;C;A	14;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	297	90.7	porB1a.l15.c30.ctg.2	513	16.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	289	291	GTA	10;10;10	G;T;A	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	222	porB1a	984	297	90.7	porB1a.l15.c30.ctg.2	513	16.9	0	.	p	.	0	D238fs	FSHIFT	712	712	G	301	301	G	12	G	12	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	690	692	AAG	160;160;162	A;A;G	158;158;160	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	0	.	p	.	0	D121G	NONSYN	361	363	GAC	693	695	GGC	162;161;160	G;G;C	161;159;159	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	0	.	p	.	0	E212D	NONSYN	634	636	GAA	966	968	GAT	177;176;178	G;A;T	168;168;170	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	0	.	p	.	0	H213G	NONSYN	637	639	CAT	969	971	GGT	175;173;171	G;G;T	170;168;157	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	0	.	p	.	0	V215A	NONSYN	643	645	GTT	975	977	GCT	171;170;167	G;C,G;T	167;163,1;160	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	0	.	p	.	0	I218M	NONSYN	652	654	ATC	984	986	ATG	169;169;169	A;T;G,T	163;163;157,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1101	1103	ACG	167;165;167	A,C;C;G	159,1;158;162	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1107	1109	GTT	167;167;169	G;T;T,A	163;158;164,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2154	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1586	133.7	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1221	1223	AAC	180;182;184	A;A;C	171;172;171	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	7518	rpoB	4179	4179	99.93	rpoB.l15.c17.ctg.1	4664	159.1	0	.	p	.	0	S558F	NONSYN	1672	1674	TCT	1944	1946	TTT	202;196;198	T;T;T	193;188;189	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	824	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1015	79.5	1	SNP	p	V57M	1	.	.	169	171	ATG	546	548	ATG	161;162;164	A;T;G	158;156;158	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	7080	tetM	1920	1920	100.0	tetM.l6.c30.ctg.1	2551	273.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
